What is Immunome's net change in cash?

Immunome (IMNM) reported net change in cash of -$70.79M in Q1 2026.

How has Immunome's net change in cash changed year-over-year?

Immunome's net change in cash decreased by 162.0% year-over-year, from $114.26M to -$70.79M.

What does net change in cash mean?

Total increase or decrease in cash during the period — the sum of operating, investing, financing cash flows plus FX effects.

Immunome IMNM Net Change in Cash

Net Change in Cash at other companies

PfizerPFE

$563M+50.1%

Arcus BiosciencesRCUS

-$21M-150%

Nuvation BioNUVB

-$38.7M-416%

SELLAS Life Sciences Group, Inc.SLS

$35.3M+143%

ArriVent BioPharma, Inc.AVBP

$16.56M+168%

IDEAYA Biosciences, Inc.IDYA

$44.96M-1.4%

Other financials

Income statement

See full

Revenue--100%

Operating income-$59.3M-32.9%

Net income-$53.8M-29.3%

EPS (diluted)-$0.48+7.7%

Balance sheet

See full

Cash & equivalents$582.7M+126%

Total debt$3.7M-22.6%

Total equity$588.7M+91.7%

Total assets$619.8M+80.9%

Cash flow

See full

Operating cash flow-$58.6M-10.5%

CapEx$3.0M-18.1%

Free cash flow-$61.6M-8.7%

Valuation

See full

Market cap$2.19B+323%

Enterprise value$1.61B+470%

P/S545.2×+498×

Profitability

See full

Operating margin-5,947.9%-12,002pp

Net margin-5,593.8%-11,284pp

FCF margin-5,118.9%-8,601pp

Returns & leverage

See full

Return on equity-50.1%-10.8pp

Debt / equity0×0.0×

Current ratio21.7×+11.2×

Where this comes from

Reported directly by Immunome in its filing.

Tagged under the XBRL concept us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect.

The official record: Immunome’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →

Ask your AI about Immunome's net change in cash.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Immunome's net change in cash?: Immunome (IMNM) reported net change in cash of -$70.79M in Q1 2026.
How has Immunome's net change in cash changed year-over-year?: Immunome's net change in cash decreased by 162.0% year-over-year, from $114.26M to -$70.79M.
What does net change in cash mean?: Total increase or decrease in cash during the period — the sum of operating, investing, financing cash flows plus FX effects.